Nantahala Capital Management, LLC / AMRX
Nantahala Capital Management, LLC’s Amneal Pharmaceuticals Inc Position
Does Nantahala Capital Management, LLC own Amneal Pharmaceuticals Inc (AMRX)? Yes — 2.84M shares worth $35M (+1.30% of its 13F portfolio) as of Q1 2026, up from 2.45M shares the prior filed quarter.
Position Value
$35M
Q1 2026
Shares
2.84M
% of Portfolio
+1.30%
Quarters Held
13
currently held
Position History AMRX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.84M | $35M | +1.30% |
| Q4 2025 | 2.45M | $31M | +1.02% |
| Q3 2025 | 4.22M | $42M | +1.47% |
| Q2 2025 | 4.37M | $35M | +1.38% |
| Q1 2025 | 3.81M | $32M | +1.27% |
| Q4 2024 | 3.67M | $29M | +1.25% |
| Q3 2024 | 2.67M | $22M | +1.12% |
| Q2 2024 | 5.34M | $34M | +0.99% |
| Q1 2024 | 2.62M | $16M | +0.91% |
| Q4 2023 | 4.67M | $28M | +0.85% |
| Q3 2023 | 2.21M | $9M | +0.80% |
| Q2 2023 | 2.15M | $7M | +0.64% |
| Q1 2023 | 500.0K | $695,000 | +0.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nantahala Capital Management, LLC’s full portfolio or all institutional holders of AMRX.